<DOC>
	<DOCNO>NCT02785146</DOCNO>
	<brief_summary>A randomize , parallel control clinical study investigate Huaier Granule prevention recurrence metastasis colorectal cancer radical surgery , evaluate efficacy safety .</brief_summary>
	<brief_title>Adjuvant Chemotherapy Combined With Huaier Granule Treating High-risk Stage II , Stage III Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>The subject volunteer sign inform consent Aged : 18 75 year old Colorectal cancer ( AJCCTNM , highrisk Stage II Stage III ) The diagnosis colorectal cancer confirm pathological examination radical surgery The liver kidney function satisfies follow condition within 15 day surgery ( exclude day 15 ) : aspartate aminotransferase ( AST ) , glutamicoxalacetic transaminase ( ALT ) , alkaline phosphatase ( ALP ) &lt; 2 upper limit normal ( ULN ) , total bilirubin ≤ 1.5 ULN , serum creatinine &lt; 1.5 ULN ; normal coagulation function Other laboratory test meet following requirement within 15 day surgery ( exclude day 15 ) : white blood cell count ≥ 3.0×109/L , absolute neutrophil count ≥ 1.5×109/L , platelet count ≥ 100×109/L ECOG：02 point No previous history malignancy . Multiple primary cancer Not recover colorectal surgery Presence organ , bone , skin metastasis Pregnant lactate woman Those active bleeding due various reason Those HIV infection AIDSassociated diseases Those severe acute chronic disease Those severe diabetes Those serious infectious disease Those take drug oral route Drug abuser psychological mental disease may interfere study compliance Conditions consider suitable study investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Huaier Granule</keyword>
	<keyword>After radical surgery</keyword>
	<keyword>Prevention recurrence metastasis</keyword>
	<keyword>Efficacy safety</keyword>
</DOC>